Carbon dioxide homeostasis regulation (None established; not a standard molecular target abbreviation.)

Carbon dioxide homeostasis regulation refers to the tightly controlled physiological mechanisms that maintain stable levels of carbon dioxide in the blood and tissues. This involves peripheral chemoreceptors—primarily located in the carotid bodies and aortic arch—that sense changes in blood PCO2 and pH. When elevated CO₂ is detected, these receptors signal respiratory centers in the brainstem to increase ventilation rate, promoting exhalation of excess CO₂ and restoring acid-base balance[1][2][3]. At the molecular level, this response involves ion channels such as connexin hemichannels sensitive to direct modification by CO₂ molecules as well as indirect effects via changes in pH mediated by enzymes like carbonic anhydrase[1]. Chronic dysregulation contributes to various diseases including COPD and congenital hypoventilation syndromes[2]. This entry does not represent a single druggable target, but rather encompasses multiple sensors, effectors, signaling pathways, and feedback loops essential for maintaining systemic acid-base equilibrium through control of respiration.

Other names

CO₂ homeostasisRegulation of carbon dioxide levelsCarbon dioxide chemosensation

Not applicable for the process itself; for related drugs: Modulation of carbonic anhydrase activity alters CO₂/bicarbonate equilibrium. CNS stimulants can increase respiratory rate and thus CO₂ elimination.